Publication Type:
Periodical
Source(s):
The Lancet; May-June 2021, Vol. 397 Issue: 10289 p2049-2059, 11p
Abstract:
Many patients with COVID-19 have been treated with plasma containing anti-SARS-CoV-2 antibodies. We aimed to evaluate the safety and efficacy of convalescent plasma therapy in patients admitted to hospital with COVID-19.